AV fistula and graft nursing: assessment, cannulation, and care

The arteriovenous fistula (AVF) and arteriovenous graft (AVG) are the lifelines of hemodialysis patients. Without a functioning vascular access, dialysis cannot happen — and without dialysis, a patient with end-stage renal disease (ESRD) has days to weeks. Nursing care of these accesses is therefore one of the highest-stakes clinical skills in nephrology nursing. Every shift, nurses are responsible for detecting the earliest signs of access failure, performing or assisting with cannulation, achieving hemostasis safely, and teaching patients how to protect and monitor their access at home.

This article covers the complete scope of AV access nursing care: anatomy and creation, maturation criteria, pre-needling assessment, cannulation techniques with evidence-based comparison, hemostasis, complication recognition, the three cardinal rules, and patient education. NCLEX high-yield points appear throughout, with a full NCLEX reference table at the end.

AV fistula vs AV graft: what they are and how they differ

An arteriovenous fistula (AVF) is a surgical connection — an anastomosis — between a nearby artery and vein, created entirely from the patient’s own tissue. The most common site is the wrist, where the radial artery is joined to the cephalic vein (radiocephalic fistula). Alternative sites include the antecubital fossa (brachiocephalic fistula) and the upper arm (brachiobasilic fistula, which requires the basilic vein to be transposed superficially). After creation, arterial pressure causes the vein to dilate, thicken, and develop a strong wall — a process called arterialization. The resulting vessel is large enough, durable enough, and close enough to the skin surface to tolerate repeated large-bore needle cannulation three times per week.

An arteriovenous graft (AVG) is created when the patient’s native vessels are too small, diseased, or exhausted for a primary fistula. A synthetic tube — almost always expanded polytetrafluoroethylene (ePTFE) — is tunneled subcutaneously to bridge the artery and vein. Because no vessel remodeling is required, the graft matures faster and can be used sooner. The tradeoff is that synthetic material carries higher infection risk, forms stenosis at the venous anastomosis, and thromboses at 6–12 times the rate of an AVF.

The choice between AVF and AVG should be part of a patient’s ESKD Life-Plan — a concept formalized in the 2019 KDOQI Vascular Access Guidelines. Rather than defaulting to “fistula first” without regard for patient prognosis, anatomy, or goals of care, the 2019 guidelines advocate for choosing the access most likely to serve the patient well for their expected treatment duration.

Maturation: when is it safe to cannulate?

Premature cannulation is one of the leading causes of AVF failure. Needling an immature access causes infiltration, hematoma, and mechanical trauma that can permanently damage the vessel before it has developed the wall strength to withstand repeated puncture.

AVF maturation — the rule of 6s

The classic maturity benchmark for an AVF is the rule of 6s, drawn from the 2006 KDOQI guidelines: at 6 weeks post-creation, the fistula should have achieved:

• ≥6 mm internal diameter — wide enough for adequate needle placement
• ≤6 mm depth from skin surface — superficial enough to cannulate reliably
• ≥600 mL/min blood flow — sufficient to meet the dialysis machine’s demand (typically 300–500 mL/min for adequate clearance)
• ≥6 cm cannulable segment length — enough length for two-needle placement with adequate distance between needles

An important update: the 2019 KDOQI Vascular Access Guidelines moved away from the rule of 6s as an absolute threshold and now emphasize clinical judgment as the primary determinant of maturity. An experienced nephrology nurse or provider who can palpate good wall thickness, a strong thrill, and an adequate vessel course contributes as much to the maturation decision as any single numeric criterion. The rule of 6s remains a useful teaching framework and initial screening tool — it is still widely used in clinical practice and tested on the NCLEX.

The physical maturation exam should confirm:

• Strong, continuous thrill palpable along the fistula
• Bruit audible with a stethoscope throughout systole and diastole
• Adequate vessel length and surface course visible on inspection
• Skin intact and healthy over the planned cannulation zone

If maturation is uncertain, duplex ultrasound is the standard adjunct evaluation.

AVG maturation

Standard ePTFE grafts require 2–4 weeks before first use — time for perigraft tissue ingrowth that controls bleeding from needle holes. Immediate-use grafts (such as Acuseal, a multi-layer ePTFE construction) have specialized outer layers that resist bleeding from the moment of implantation; these may be cannulated within 24–72 hours of placement per manufacturer protocol and surgeon preference. Grafts feel firm and tube-like under the skin; the arterial and venous anastomoses are usually marked by the surgeon to orient cannulation direction.

Pre-needling assessment: thrill, bruit, and inspection

Before every cannulation, a structured access assessment is non-negotiable. This assessment detects problems before needles are placed — an infiltrated or clotted access can result in session cancellation, emergent intervention, or permanent access loss.

Step 1: Palpate for thrill

A thrill is the continuous vibration felt when you place your fingertips over the fistula or graft anastomosis. It reflects turbulent blood flow where high-pressure arterial blood enters the low-resistance venous system. The thrill should be:

• Continuous — present throughout the cardiac cycle, strongest at the anastomosis
• Soft and buzzy — like holding your hand over a purring motor

Palpation findings to act on:

• Absent thrill — possible thrombosis; do not cannulate; notify the dialysis care team or vascular surgeon immediately
• Thrill only during systole (pulsatile) — suggests outflow stenosis; the access is fighting against elevated downstream resistance and bouncing rather than flowing freely; report before cannulating
• Thrill present but weaker than baseline — possible developing stenosis; document and report

Step 2: Auscultate for bruit

Place the diaphragm of the stethoscope over the access. A normal bruit is a low-pitched, swooshing sound that continues through both systole and diastole — a continuous bruit.

Auscultation findings to act on:

• Absent bruit — supports thrombosis; do not cannulate; emergent referral
• High-pitched, loud bruit — suggests stenosis just upstream; high-velocity flow through a narrowed segment produces a higher pitch
• Bruit only in systole — outflow obstruction; blood cannot freely leave the system during diastole

Step 3: Visual inspection of the access site

Inspect the entire cannulable segment before choosing needle placement sites:

• Skin integrity: Look for aneurysmal dilation, thinning skin, necrotic areas, or eschar — these zones are contraindicated for needling
• Prior needle sites: In rope-ladder technique, rotate away from previously used sites. In buttonhole technique, identify the established tunnel sites by their characteristic healed puncture appearance
• Infection signs: Erythema, warmth, induration, purulent discharge, or fluctuance — any of these requires the session to be postponed pending evaluation; do not cannulate through or near a suspected infection
• Hematoma: Residual bruising from previous sessions; needle away from active hematoma
• Graft integrity: Inspect the full graft course for pseudoaneurysm (pulsatile bulge that does not reduce on digital compression)

Step 4: Distal extremity check

Assess the hand and fingers distal to the access for color, temperature, capillary refill, sensation, and radial pulse. Comparing to the contralateral hand identifies subtle changes. This check is the foundation of steal syndrome detection — if the hand is cooler, more mottled, or the patient reports hand pain or numbness, flag before starting the session (see Complications section).

Cannulation technique: buttonhole, rope-ladder, and area technique

Three cannulation techniques are used in clinical practice. The choice is made by the dialysis unit, informed by individual patient factors, access anatomy, and institutional protocol.

Rope-ladder (rotating sites) technique

The rope-ladder technique distributes cannulation along the entire length of the access by systematically rotating needle placement sites from session to session, spacing each puncture approximately 1–2 cm from the previous. This creates a pattern resembling a ladder along the access length.

Mechanism of protection: By distributing trauma across many sites, the rope-ladder approach prevents the aneurysm formation that results from repeatedly hitting the same spot of vessel wall. Each section of the access vessel has time to heal before it is cannulated again.

Evidence: The KDOQI 2019 guidelines and multiple systematic reviews — including a 2022 PMC meta-analysis of RCTs — consistently show that rope-ladder carries lower infection rates than buttonhole. In one RCT, the rate of localized infection with rope-ladder was 22.4 per 1,000 sessions versus 50 per 1,000 sessions with buttonhole (P = 0.003), and buttonhole was associated with higher rates of Staphylococcus aureus bacteremia.

Requirements: The access must have sufficient cannulable length — at least 6 cm, ideally more. Requires fresh sharp needles every session.

Buttonhole (constant site) technique

The buttonhole technique involves cannulating the exact same two puncture sites at the same angle, same depth, and same direction every session. Over multiple sessions (typically 8–12 punctures), the repeated trauma creates a fibrous tunnel track — a “buttonhole” — through the skin and vessel wall. Once the track is established, dull (blunt-tip) needles follow the existing track rather than piercing new tissue.

Mechanism of benefit: Blunt needles entering an established track cause less pain and anxiety, particularly for home hemodialysis patients who self-cannulate. Some patients with difficult access anatomy (very deep fistulas, limited segment length) cannot accommodate rope-ladder rotation and benefit from the predictability of fixed sites.

Infection risk — the evidence: Buttonhole has a well-documented higher infection rate than rope-ladder in facility-based hemodialysis. The eschar (scab) that forms over each buttonhole site between sessions is frequently colonized with bacteria — predominantly Staphylococcus aureus. If the eschar is not completely removed before cannulation, bacteria are introduced directly into the bloodstream. A 2014 systematic review in the American Journal of Kidney Diseases confirmed increased risk of AVF-related bacteremia and local infection with buttonhole versus rope-ladder. The 2019 KDOQI guidelines state: “Evidence does not support the preferential use of buttonhole over rope-ladder cannulation” in either facility or home HD. Buttonhole remains appropriate for carefully selected patients, particularly home HD patients who self-cannulate and can maintain rigorous scab removal technique.

Buttonhole cannulation protocol:

1. Remove the scab completely using a single-use scab remover or sterile forceps — do not skip this step
2. Cleanse the site with chlorhexidine or povidone-iodine per protocol; allow full dry time
3. Insert the blunt needle at the exact established angle and depth; if resistance is met, do not force — use a sharp needle to reset the track
4. Confirm placement by blood return before advancing

Area (constant zone) technique

The area technique — also called zone cannulation — confines needles to a defined anatomical zone rather than a true single buttonhole site. It is a middle ground between buttonhole and rope-ladder that is sometimes used when access length is limited.

Disadvantage: By concentrating trauma in a small zone, area technique carries the same aneurysm risk as buttonhole without the track benefit of blunt needles. Most guidelines do not recommend it over true rope-ladder when cannulable length permits.

Cannulation procedure — technique for both AVF and AVG

Equipment: 15G or 16G AV fistula needles (17G used for smaller access or maturation sessions), tourniquet, chlorhexidine or povidone-iodine, sterile gloves, tape, and tubing connectors.

Needle placement:

• Two needles are placed: the arterial needle (draws blood from the patient to the machine) and the venous needle (returns blood to the patient). Despite the names, both needles sit within the fistula or graft — the terms refer to the direction of flow.
• The arterial needle is placed toward the arterial anastomosis (antegrade with arterial flow) or antegrade in the direction of blood flow through the access.
• The venous needle is placed downstream, oriented in the direction of venous outflow, with at least 5–8 cm separation from the arterial needle to prevent recirculation (where cleaned blood is immediately re-drawn into the arterial line).
• Cannulation angle: 25–45° — steep enough to enter the vessel cleanly, shallow enough to avoid back-walling. Once the needle tip is in the lumen (confirmed by blood return), flatten the angle to 15–20° and advance.
• The bevel is typically positioned upward for initial entry into an AVF. Bevel orientation does not significantly change hemostasis time per current evidence, but facility protocols vary.

Blood flow targets: Most in-center HD protocols target blood flow rates of 300–450 mL/min. Rates below 300 mL/min result in inadequate dialysis adequacy (Kt/V below target). If the access cannot sustain the prescribed flow rate, this is a clinical sign of stenosis or maturation failure and should be documented and reported.

Hemostasis after needle removal

After each dialysis session, achieving safe hemostasis is a critical nursing responsibility. Dialysis patients receive heparin during every session (systemic anticoagulation to prevent circuit clotting), and the large-bore needles (15–16G) create substantial puncture wounds in a high-flow vessel. Failure to achieve adequate hemostasis causes hematoma, access injury, and — in extreme cases — life-threatening hemorrhage.

Technique

1. Remove the venous needle first, then the arterial needle — or per facility protocol. Some units remove both simultaneously with two nurses.
2. Apply two-finger pressure using sterile gauze directly over the needle insertion site on the skin and simultaneously over the vessel entry point just above it. The two-point pressure ensures that both the skin puncture and the vessel wall puncture are occluded.
3. Apply firm but not occlusive pressure — enough to stop bleeding without collapsing the vessel lumen. The thrill and bruit must remain palpable and audible above and below the compression zone. If you cannot feel the thrill during compression, you are pressing too hard and risking thrombosis.
4. Maintain compression without releasing for a minimum of 10 minutes for an AVF and 10–15 minutes for an AVG. Patients who have received higher heparin doses or who are on warfarin/antiplatelet agents may require longer compression.
5. Once hemostasis is confirmed, apply a small sterile bandage — not a circumferential wrap or pressure dressing that could compress the access.

Warning signs during hemostasis

• Bleeding beyond 15 minutes despite adequate technique — suggests outflow stenosis causing elevated intraluminal pressure; document and report to the care team
• Expanding hematoma during compression — suggests the vessel was not properly occluded or the needle tip moved; increase pressure, alert the charge nurse
• Pulsatile bleeding — suggests arterial needle site; apply firmer pressure; do not release

Complications of inadequate hemostasis

• Hematoma: Blood escapes into the perivascular tissue. Small hematomas resolve spontaneously; large hematomas can cause compartment syndrome and compress the access.
• Pseudoaneurysm: Repeated incomplete hemostasis at the same site allows blood to track into a pulsatile perivascular sac; requires surgical referral.
• Access loss: Severe hemorrhage can require emergent ligation.

Recognizing access complications

Early identification of complications prevents access loss and keeps patients out of the hospital. Every pre-session assessment and post-session observation is an opportunity to catch a problem before it becomes irreversible.

Steal syndrome in detail

Steal syndrome occurs when the AV access creates a low-resistance shunt that diverts arterial blood away from the distal hand. The 5 Ps — Pain, Pallor, Pulselessness, Paresthesia, Paralysis — mirror the classic presentation of acute limb ischemia and come from the same underlying process: inadequate arterial perfusion to the tissues distal to the access. The 5 Ps are on the NCLEX.

Key clinical distinction: the symptoms characteristically worsen during dialysis when the machine adds additional flow demand on the access, and improve when the access is compressed manually. Improvement with compression is a diagnostic finding — it confirms that the access, not arterial occlusive disease, is the cause.

Steal syndrome is most common after brachial artery-based access creation (brachiocephalic AVF, upper arm AVG) because the brachial artery supplies the entire forearm and hand. It occurs in up to 5–8% of brachial-based accesses and is rare with radiocephalic (wrist) fistulas. Mild steal may be managed conservatively; severe or progressive steal requires surgical intervention.

The three cardinal rules of AV access protection

Three absolute rules apply to every patient with a functioning AV access. These rules are tested on the NCLEX and must be communicated to every care provider who encounters the patient, whether on the dialysis unit, the hospital floor, the emergency department, or the pre-op holding area.

Rule 1: No blood pressure measurement in the access arm

Why: A blood pressure cuff inflates to above systolic pressure, temporarily occluding the artery supplying the access. This interruption of flow in a high-flow system promotes thrombus formation. The compression also applies direct mechanical force to a vessel wall that may already have needle puncture sites or developing aneurysmal changes. In a thrombosis-prone AVG, a single BP measurement has been associated with acute thrombosis.

What to do instead: Measure blood pressure in the contralateral arm. If both arms have accesses, use a thigh cuff per provider order, or use a non-invasive finger monitor. Document the alternative site used.

Rule 2: No venous access (IV insertion) in the access arm

Why: IV catheter insertion introduces a second puncture site in a limb already under infection risk from dialysis needling. More critically, IV fluids — especially large volumes — increase venous pressure in the arm, raising the risk of venous hypertension and access dysfunction. An infiltrated IV in the access arm can also introduce bacteria into the perivascular tissue. See the IV insertion reference for peripheral IV principles and contraindicated sites.

What to do instead: Place all peripheral IVs in the opposite arm. If bilateral access is present, notify the care team and consider central access or a PICC — with nephrology guidance.

Rule 3: No blood draws (phlebotomy) from the access arm

Why: Venipuncture from any site in the access arm — including the antecubital fossa, wrist, or dorsum of the hand — compresses and samples from the venous system that feeds the access. This risks hematoma formation, thrombosis of a small tributary feeding the fistula, and direct contamination of the access circuit. See venipuncture nursing for proper site selection principles.

What to do instead: Draw all blood from the contralateral arm. Blood can also be drawn directly from the dialysis circuit with nephrologist approval at the start of the session.

Labeling and communication

The access arm must be labeled in the medical record (allergy/alert field), on the patient’s armband if in-hospital, and verbally communicated at every handoff. Teach the patient to self-advocate: they should inform every nurse, phlebotomist, and anesthesiologist about the access before any procedure. Patients should wear a medical alert bracelet identifying the access arm.

Infiltration management

Infiltration occurs when the dialysis needle is not correctly placed within the vessel lumen, or when it is dislodged during the session, causing blood to extravasate into the surrounding tissue. It is more common in inexperienced hands and in patients with tortuous, difficult-to-palpate accesses.

Presentation: The patient typically reports pain, burning, or pressure at the needle site. Swelling and firmness at the cannulation site confirm extravasation. Blood flow on the machine drops and arterial pressure alarms sound.

Immediate management:

1. Stop the blood pump; do not remove the needle yet until the extent of the problem is assessed
2. If infiltration is confirmed, withdraw the needle and apply firm direct pressure
3. Do not attempt to re-cannulate the same site
4. Apply ice to the affected area for the first 20–30 minutes to reduce hematoma expansion
5. If the session must continue, the other needle may remain in place while a new needle is placed at a different site — or the session may need to be rescheduled depending on the severity of the infiltration and access integrity

Post-infiltration monitoring: Document the size of the hematoma at the time of the event and monitor for expansion. Hematoma resolution typically takes 1–3 weeks. Large hematomas that compress the access vessel may require aspiration or surgical evacuation. Instruct the patient to apply warm compresses after the initial 24 hours to promote reabsorption.

Repeated infiltrations at the same site indicate a training or technique issue and should be escalated to the charge nurse and access coordinator.

Patient education: protecting the access at home

Patient education is one of the most impactful things a dialysis nurse does. The patient lives with the access 24 hours a day; the nursing team sees it three times per week. Patients who understand their access and know what to report protect it far better than those who do not.

Daily access monitoring

Teach the patient to perform a daily home access check:

• Feel for the thrill every morning — place two fingers lightly over the fistula or along the graft. The vibration should be present and feel the same as usual.
• Listen if able — some patients learn to use a simple stethoscope at home; a continuous whoosh confirms flow.
• If the thrill is absent — call the dialysis unit immediately, even outside business hours. Every hour matters when a thrombosis is developing. Thrombectomy is far more successful when performed within 24 hours of clotting.

After a dialysis session

• Apply a small bandage; keep it on for the remainder of the day
• Do not lift heavy objects or perform vigorous arm exercise on dialysis days — high venous pressure from exertion can reopen needle sites
• Mild exercise (gentle squeezing with a stress ball) between sessions promotes fistula development and blood flow — this is particularly important in the maturation period
• Keep the access site clean and dry; avoid soaking in a bathtub or swimming in public pools (increased infection risk)
• Showering is fine; gently clean over the access with soap and water

Activity restrictions

• No tight sleeves, wristwatches, or compression garments over the access arm
• Do not sleep on the access arm — prolonged compression is a thrombosis risk
• Avoid blood pressure cuffs, IVs, and blood draws — the patient must communicate this to every healthcare provider they encounter

Warning signs requiring immediate contact

Teach patients to call the unit without waiting for the next scheduled session if they notice:

• Absent thrill or bruit
• Significant redness, swelling, warmth, or pus at the access site
• Fever above 38°C (100.4°F) — may indicate access-related bacteremia
• Unusual bleeding from needle sites after leaving the unit
• Severe hand pain, coldness, or numbness (steal syndrome)
• The access looks or feels different from normal in any way they cannot explain

Nutrition and access health

Remind patients that dehydration is a risk factor for access thrombosis. Maintaining adequate hydration between sessions (within their prescribed fluid restriction) and avoiding large-volume interdialytic weight gains that necessitate aggressive ultrafiltration both support access longevity. Point patients with CKD/ESRD toward their renal dietitian for individualized fluid, potassium, and phosphorus guidance.

NCLEX high-yield tips: AV fistula and graft nursing

The following 20 high-yield NCLEX tips cover the concepts most commonly tested on the NCLEX related to AV access nursing.

NCLEX practice scenarios

How this article connects to related nursing content

Vascular access care is one component of a broader renal replacement therapy picture. For the complete nursing management of a hemodialysis session — including machine setup, intradialytic monitoring, ultrafiltration management, and dialysis disequilibrium syndrome — see the hemodialysis nursing reference. Patients choosing peritoneal dialysis avoid vascular access entirely; understanding both modalities is essential for CKD/ESRD nursing.

Critical lab interpretation skills — potassium, phosphorus, BUN, creatinine, and bicarbonate — are essential in dialysis patients; see critical lab values nursing for a full reference. For nurses who encounter dialysis patients in the inpatient setting, a solid foundation in IV insertion principles prevents inadvertent access arm violations, and venipuncture nursing covers the correct approach to blood draws in patients with complex vascular access considerations. Dialysis patients with AKI may receive temporary hemodialysis via central venous catheter rather than a permanent access — see the AKI reference for the acute management context.

Sources

1. Lok CE, Huber TS, Lee T, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. American Journal of Kidney Diseases. 2020;75(4 Suppl 2):S1–S164. https://www.ajkd.org/article/S0272-6386(19)31137-0/fulltext

2. Murea M, Lok CE. KDOQI 2019 Vascular Access Guidelines: What Is New. PMC/NCBI. 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC8856770/

3. Vaux E, King J, Lloyd S, et al. Effect of buttonhole cannulation with a polycarbonate peg on in-center hemodialysis fistula outcomes: a randomized controlled trial. American Journal of Kidney Diseases. 2013;62(1):81–88. PMID: 23352378.

4. Grudzinski A, Mendelssohn D, Pierratos A, Nesrallah G. A systematic review of buttonhole cannulation practices and outcomes. Seminars in Dialysis. 2013;26(4):465–475.

5. Wang J, Luo Y, Liu J, et al. Effect of buttonhole cannulation versus rope-ladder cannulation in hemodialysis patients with vascular access: a systematic review and meta-analysis. PMC/NCBI. 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9302278/

6. Dinwiddie LC, Bhola C, Bhola C. Buttonhole cannulation of arteriovenous fistulas: a dialysis nurse’s perspective. PMC/NCBI. 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC8809277/

7. Smith GE, Gohil R, Chetter IC. Factors affecting the patency of arteriovenous fistulas for dialysis access. Journal of Vascular Surgery. 2012;55(3):849–855.

8. Malik J, Lomonte C. Arteriovenous access failure, stenosis, and thrombosis. PMC/NCBI. 2017. https://pmc.ncbi.nlm.nih.gov/articles/PMC5332078/

9. Dialysis Fistula. StatPearls. NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK559085/

10. Care of needling sites after hemodialysis. St. Joseph’s Healthcare Hamilton. https://www.stjoes.ca/patients-visitors/patient-education/patient-education:-f-j/care-of-needling-sites-after-hemodialysis-pdf